medigraphic.com

2012, Number 5

AMC 2012; 16 (5)

Presence of septic complications in definite endocardial pacemakers

Castellanos RR, Segura PLA, Sanchén CA, Ferrer HIM

Language: Spanish
References: 24
Page: 1562-1572
PDF size: 239.93 Kb.


ABSTRACT

Background: definite endocardial pacemaker implantation may be accompanied by septic complications that darken its prognosis, hence the importance of its study. Objective: to describe the behavior of septic complications of definite endocardial pacemakers in patients at the Cardiovascular Care Center in Camagüey, from 2001 to 2009. Method: a crosssectional descriptive study was conducted in a universe of 49 patients with septic complications, whose secondary record was their medical histories and the register of pacemaker implantation, the studied variables were: age group, sex, type of septic complications, germs, antimicrobial susceptibility, type of pacemaker most prone to complicate and way of implementation. Data were computeroperated, descriptive statistics through absolute and relative summary measures were used. Results: septic complications in the group of 60 years and older prevailed. Surgical wound sepsis and the one from the pocket were the most frequent, as well as Staphylococcus aureus germ, most of the germs showed resistance. Venipuncture and dual chamber complicated pacemakers prevailed. Conclusions: septic complications predominated in patients over than 60 years, regarding dual chamber and venipuncture pacemaker. Staphylococcus aureus was the most frequent germ, resistance to treatment was observed.


REFERENCES

  1. Kursaklioglu H, Barcin C, Iyisoy A, Kose S, Isik E. Percutaneous transcatheter repositioning of displaced permanent pacemaker atrial lead with a simple system. Int J Cardiovasc Intervent [Internet]. 2004 [citado 1 Mar 2006];6(2): [aprox. 9 p.]. Disponible en: http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=15385209&query_hl=6&itool =pubmed_docsum

  2. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guías europeas de práctica clínica sobre marcapasos y terapia de resincronización cardíaca. Rev Esp Cardiol. 2007;60(12):e1e51.

  3. Klug D, Marquie C, Lacroix D, Kacet S. Complications of permanent cardiac pacing. Arch Mal Coeur Vaiss [Internet]. 2003 Dec [citado 1 Mar 2006];96(7) [aprox. 12 p.]. Disponible en: http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=15272521&query_hl=4&itool =pubmed_DocSum

  4. Cuba. Ministerio de Salud Pública. Instituto Nacional de Higiene, Epidemiología y Microbiología. Normas de Microbiología. La Habana: MINSAP; 1981.

  5. Kirby V, Bauer A, Sherris J, Truck M. Antibiotic suseptibility testing by standrized single disk method. Am J.Clin Patholol. 1996; 45(4):4945.

  6. Hayes D, Zipes D. Marcapasos y cardioversores. En: Braunwald, editor. Tratado de Cardiología. 7ma ed. España: Elsevier S.A; 2006.p. 76782

  7. Scaglione J, De Palma CA, Heredia R, Justich PR. Marcapasos y cardiodesfibriladores implantables. Pacing Clin Electrophysiol [Internet]. 2004 Jul [citado 1 Mar 2006];25(1): [aprox. 7 p.]. Disponible en: http://72.14.207.104/search? q=cache:a1vmqF77f_EJ:www.elizalde.go v.ar/area_medica/Revista/vol1_2004/ marcapaso.PDF+marcapasos+permanen tes+complicaciones&hl=es&gl=cu&ct=cln k&cd=5&l

  8. Bharat V. Redo surgery after permanent pacemaker implantation: performance indicator of surgical techniques and pacing technology. Indian Heart J [Internet]. 2004 JanFeb [citado 1 Mar 2006];56(1):[aprox. 9 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=15129789&query_hl=22&ito ol=pubmed_docsum

  9. Coma Samartin R, García Calabozo R, García Calabozo R, Martínez Ferrer J, Sancho Tello MJ, Ruiz Mateas F. Registro Español de Marcapasos. III Informe Oficial de la Sección de estimulación Cardiaca de la Sociedad Española de cardiología (2005). Rev Esp Cardiol. 2006; 59(12):130313

  10. Garcia Guerrero JJ, De La Concha Castaneda JF, Fernandez Mora G, Lopez Quero D, Redondo Mendez A, Davila Davila E, et al. Permanent transfemoral pacemaker: a singlecenter series performed with an easier and safer surgical technique. Pacing Clin Electrophysiol [Internet]. 2005 Jul [citado 1 Mar 2006];28(7):[aprox. 9 p.]. Disponible en: http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=16008803&query_hl=27&ito ol=pubmed_docsum

  11. Dora SK, Kumar VK, Bhat A, Tharakan JA. VenogramGuided Extrathoracic Subclavian Vein Puncture. Indian Heart J [Internet]. 2003 NovDec [citado 1 Mar 2006];55(6):[aprox. 6 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=14989516&query_hl=25&ito ol=pubmed_docsum

  12. Lakkireddy D, Valasareddi S, Ryschon K, Basarkodu K, Rovang K, Mohiuddin SM, et al. The impact of povidoneiodine pocket irrigation use on pacemaker and defibrillator infections. Pacing Clin Electrophysiol [Internet] 2005 Aug [citado 1 Mar 2006];28(8):[aprox. 6 p.]. Disponible en: http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=16105006&query_hl=28&ito ol=pubmed_docsum

  13. Dwivedi SK, Saran RK, Khera P, Tripathi N, Mochar AK, Narain VS. Shortterm (48 hours) versus longterm (7 days) antibiotic prophylaxis for permanent pacemaker implantation. Indian Heart J [Internet]. 2001 NovDec [citado 1 Mar 2006];53(6):[aprox. 8 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=11838927&query_hl=30&ito ol=pubmed_docsum

  14. Graham AS, Ozment C, Tegtmeyer K, Lai S,Braner AV. Central Venous Catheterization. N Engl J Med. 2008; 356:219.

  15. Brook G, Butel J, Nicholas O. Microbiología Médica de Jawetz E, Melnick J, Adelberg E. La Habana: ECIMED; 2006

  16. Cota G, Campo J, Ramos J. Epidemiología da Meningitis aguda entre adultos en un centro de referencia em doencas infecciosas em Minas Gerais. Ver Brazil Med. 2006; 63(6):2747.

  17. Costa MA, Wollmann DR, Campos AC, Cunha CL, Carvalho RG, Andrade DF, et al. Risk index for death by infective endocarditis: a multivariate logistic model. Rev Bras Cir Cardiovasc. 2007; 22(2):192200.

  18. Klug D, Lacroix D, Savoye C. Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management. Circulation. 2008; 95:20982107.

  19. Resúmenes de Trabajos Libres del XIV Congreso Nacional de Cardiología. Rev Mex Cardiol. 2010; 21(4):1614.

  20. Klug D, Balde M, Pavin D. Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: results of a large prospective study. Circulation. 2007; 116 (12):134955.

  21. Jenkins SM, Hawkins NM, Hogg KJ. Pacemaker endocarditis in patients with prosthetic valve replacements: case trilogy and literature review. Pacing Clin Electrophysiol. 2008; 30(10):127983.

  22. Furuya EY. Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Phar. 2008; 3(5):469.

  23. Jassal DS, Weyman AF. Infective endocarditis in the era of intracardiac devices: and echocardiographic perspective. Rev Cardiovasc Med. 2006; 7(3):1129.

  24. Aggarwal K, Tejwani L. Bugs and clots: the value of transesophagealechocardiography in defining permanent pacemaker lead infections. J Invasive Cardiol. 2009; 18 (12):6023.




2020     |     www.medigraphic.com